financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Sell Opinion On Shares Of Molson Coors Beverage Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Sell Opinion On Shares Of Molson Coors Beverage Company
May 2, 2026 11:49 AM

02:25 PM EDT, 05/02/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target by $5 to $35, based on a 2027 P/E of 7.0x, a justified discount to TAP's five-year average forward P/E of 11.4x. We raise our adjusted EPS estimates by $0.20 to $4.90 for '26 and by $0.10 to $5.10 for '27. Following TAP's Q1 earnings release, we are lowering our price target and maintaining a Sell opinion on the shares. TAP posted Q1 adjusted EPS of $0.62 vs. $0.50 (+24%), well ahead of the $0.36 consensus. The beat was due to stronger-than-expected sales and margins, as net sales rose 2.0% to $2.35B ($25 above consensus) on a 2.9% drop in financial volume and gross margin expanded 130 bps to 38.2% (350 bps ahead of consensus). While TAP's Q1 earnings were well ahead of expectations, the fact that it didn't increase full-year guidance raises concerns that the balance of the year will be weaker than previously anticipated, with positive foreign exchange impacts likely to be less favorable than in Q1. We struggle to identify a catalyst and see the demand environment remaining challenging.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc.
May 11, 2026
09:15 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target to $84 from $98, based on 16.9x our 2027 EPS estimate, below GMED's five-year average forward P/E multiple. We raise our 2026 EPS view to $4.72...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Devon Energy Corporation
Research Alert: CFRA Maintains Sell Opinion On Shares Of Devon Energy Corporation
May 11, 2026
07:20 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $42, raised $2, reflects relative valuation and our DCF models. On a relative basis, we apply a 4.5x multiple of enterprise value to projected 2027...
Research Alert: CFRA Lifts Opinion On Shares Of Nrg Energy, Inc. To Buy From Hold
Research Alert: CFRA Lifts Opinion On Shares Of Nrg Energy, Inc. To Buy From Hold
May 11, 2026
10:10 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price is unchanged at $189, valuing shares at 19.2x our next-12-month EPS estimate of $9.86, slightly below IPP peers averaging 19.5x but significantly above NRG's highly volatile...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Albemarle Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Albemarle Corporation
May 11, 2026
08:00 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $43 to $229, valuing ALB at 27.1x on our 2027 EPS estimate, a premium to ALB's normalized average fwd P/E during the last...
Copyright 2023-2026 - www.financetom.com All Rights Reserved